Passive Equities

First Trust Capital Strength ETF

The First Trust Capital Strength® ETF (the “Fund”) seeks investment results that correspond generally to the price and yield (before the Fund’s fees and expenses) of an equity index called The Capital StrengthTM Index (the “Index”).

$92.73

Key Metrics

TER 53.00% per year
Distribution policy Distributing
Fund size USD 7,853 M
Inception date July 6, 2006
Holdings 51
Fund currency USD
Fund domicile US
Provider First Trust
For full official fund details, factsheets, and holdings, visit ftportfolios.com (opens in new tab).

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Capital Strength ETF FTCS
Fund Size
$7.86B
Dividend
1.1%
Fees
53.00%
Total Stock Market Index Fund VTSAX
Fund Size
$1.99T
Dividend
1.0%
Fees
4.00%
Total Stock Market Index Fund VTI
Fund Size
$1.99T
Dividend
1.0%
Fees
3.00%
500 Index Fund VFINX
Fund Size
$1.42T
Dividend
0.9%
Fees
-
500 Index Fund VFIAX
Fund Size
$1.42T
Dividend
1.0%
Fees
4.00%
View 1334 similar ETFs →

Historical Return

Last updated: Jun 15, 2026
1 Year +4.8% +1.1% Div
3 Years (avg.) +8.3% +1.1% Div
5 Years (avg.) +4.7% +1.1% Div

Risk & Analysis Metrics

Last updated: Jun 15, 2026

Volatility

9.36% 1 Year
10.87% 3 Years
12.91% 5 Years
15.41% 10 Years

Max Drawdown

-8.02% 1 Year
-13.22% 3 Years
-21.63% 5 Years
-31.93% 10 Years

Sharpe Ratio

0.04 1 Year
0.36 3 Years
0.07 5 Years
0.36 10 Years

Return Triangle (Heatmap)

Last updated: Jun 15, 2026
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2011 -5.6% 2.1% 10.8% 11.8% 9.4% 9.3% 11.3% 9.0% 10.7% 10.7% 12.1% 10.1% 9.8% 9.8% 9.5%
2012 10.5% 20.1% 18.2% 13.5% 12.5% 14.4% 11.3% 13.0% 12.7% 14.1% 11.6% 11.2% 11.1% 10.7%
2013 30.6% 22.3% 14.5% 13.0% 15.2% 11.4% 13.3% 13.0% 14.5% 11.7% 11.3% 11.1% 10.7%
2014 14.6% 7.3% 7.7% 11.6% 7.9% 10.7% 10.7% 12.6% 9.8% 9.5% 9.5% 9.2%
2015 0.4% 4.4% 10.7% 6.3% 9.9% 10.1% 12.4% 9.2% 9.0% 9.0% 8.7%
2016 8.6% 16.2% 8.4% 12.4% 12.1% 14.5% 10.5% 10.1% 10.0% 9.6%
2017 24.3% 8.3% 13.7% 13.0% 15.7% 10.9% 10.3% 10.2% 9.7%
2018 -5.7% 8.7% 9.5% 13.7% 8.4% 8.1% 8.3% 8.0%
2019 25.4% 18.0% 21.0% 12.2% 11.1% 10.9% 10.1%
2020 11.0% 18.8% 8.1% 7.8% 8.2% 7.8%
2021 27.2% 6.7% 6.8% 7.5% 7.2%
2022 -10.4% -2.1% 1.6% 2.7%
2023 7.0% 8.2% 7.4%
2024 9.5% 7.7%
2025 5.9%

Distributions

*by ETF Portfolio Weight Last updated: Jun 15, 2026

Profit Margin Distribution

< 0%
0%
1y 3y N/A N/A
0 - 5%
8%
1y 3y N/A N/A
5 - 10%
19%
1y 3y N/A N/A
10 - 15%
22%
1y 3y N/A N/A
15 - 20%
6%
1y 3y N/A N/A
20 - 30%
30%
1y 3y N/A N/A
30 - 40%
9%
1y 3y N/A N/A
> 40%
6%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
0%
1y 3y N/A N/A
0 - 10
2%
1y 3y N/A N/A
10 - 15
14%
1y 3y N/A N/A
15 - 20
14%
1y 3y N/A N/A
20 - 25
23%
1y 3y N/A N/A
25 - 35
32%
1y 3y N/A N/A
35 - 50
13%
1y 3y N/A N/A
> 50
2%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
0.0%
1y 3y N/A N/A
Small Cap
0.0%
1y 3y N/A N/A
Mid Cap
0.0%
1y 3y N/A N/A
Large Cap
73.2%
1y 3y N/A N/A
Mega Cap
26.8%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Jun 15, 2026
12.1% Top 5 Holdings
23.1% Top 10 Holdings
100.0% Top 50 Holdings
100.0% Top 100 Holdings
Top 5 Companies
EOG EOG Resources, Inc.
2.8%
LIN Linde Plc
2.3%
ROST Ross Stores, Inc.
2.3%
JNJ Johnson & Johnson
2.3%
GILD Gilead Sciences, Inc.
2.3%

Latest News

12 days ago • prnewswire.com

IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven disease with no FDA-approved therapies

Patients in the IMAAVY 30 mg/kg treatment group a achieved statistically significant durable hemoglobin response b , with mean hemoglobin improveme...

13 days ago • 247wallst.com

I Would Rebuild My Portfolio With Just These 3 Stocks If I Lost Everything Tomorrow

I keep buying NVIDIA, Eli Lilly, and Johnson & Johnson, and if a fire took my brokerage statement to zero tomorrow, those are the three tickers I w...

13 days ago • 247wallst.com

The Portfolio That Gets You a Waterfront Condo in Miami Beach

Ten thousand dollars a month in dividend income works out to $120,000 per year. That is enough to cover the rent on a luxury waterfront condo in Mi...

Average metrics of all companies in portfolio

Last updated: Jun 21, 2026
Market
Average
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $302B -
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 1.70% 2.03%
Beta Indicates the relationship between the price performance of a share and the market. 0.69 -
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 26.98 28.29
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything - -
Profitable Companies 100% -
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 33.01 14.56
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 4.84 8.28
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 10.21 10.72
Market
Average
Enterprise Value to EBIT Enterprise Value divided by EBIT 21.67 21.15
Enterprise Value to Revenue Enterprise value divided by revenue 5.0 8.72
Total Debt to Enterprise Value Total debt divided by enterprise value 0.11 0.05
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 2.29 0.33
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 18.89% -6.18%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. +12.9% -117.9%
Return on Equity Equity divided by market cap. 38.47% 1.23%
Return on Assets Indicates a company's profitability in relation to its total assets. 11.37% 3.29%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 21.06% 3.31%

Sectors

Manufacturing 43.8%
Finance and Insurance 15.5%
Retail Trade 12.2%
Information 10.4%
Mining, Quarrying, and Oil and Gas Extraction 2.8%
Other Services (except Public Administration) 2.1%
Finance 2.0%
Wholesale Trade 1.8%
Construction 1.8%
Professional, Scientific, and Technical Services 1.7%
Administrative and Support and Waste Management and Remediation Services 1.7%
Other 4.2%

Countries

United States 95.8%
United Kingdom 2.1%
Ireland 1.9%
Other 0.2%

Stock Screener

Select filters to narrow down the 50 investments below

50 companies

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%

Loading details…

Market Cap $236.92B
P/E Ratio 33.4
Dividends 1.2%
Total Investment $183.48M
Weight 2.34%

Loading details…

Market Cap $74.68B
P/E Ratio 32.1
Dividends 0.7%
Total Investment $182.95M
Weight 2.33%

Loading details…

Market Cap $549.78B
P/E Ratio 26.5
Dividends 2.3%
Total Investment $181.61M
Weight 2.31%

Loading details…

Market Cap $153.66B
P/E Ratio 16.7
Dividends 2.6%
Total Investment $181.26M
Weight 2.31%

Loading details…

Market Cap $341.57B
P/E Ratio 24.9
Dividends 2.6%
Total Investment $175.39M
Weight 2.23%

Loading details…

Loading details…

Market Cap $194.13B
P/E Ratio 22.2
Dividends 4.0%
Total Investment $172.41M
Weight 2.20%

Loading details…

Market Cap $31.86B
P/E Ratio 6.9
Dividends 0.0%
Total Investment $172.03M
Weight 2.19%

Loading details…

Market Cap $35.02B
P/E Ratio 31.3
Dividends 3.3%
Total Investment $170.78M
Weight 2.17%

Loading details…

Market Cap $932.53B
P/E Ratio 40.5
Dividends 0.8%
Total Investment $168.67M
Weight 2.15%

Loading details…

Market Cap $117.81B
P/E Ratio 24.5
Dividends 2.7%
Total Investment $168.58M
Weight 2.15%

Loading details…

Market Cap $421.95B
P/E Ratio 47.8
Dividends 0.6%
Total Investment $167.99M
Weight 2.14%

Loading details…

Market Cap $471.16B
P/E Ratio 39.6
Dividends 1.4%
Total Investment $167.64M
Weight 2.13%

Loading details…

Market Cap $145.11B
P/E Ratio 35.4
Dividends 2.1%
Total Investment $167.37M
Weight 2.13%

Loading details…

Market Cap $26.07B
P/E Ratio 21.2
Dividends 1.2%
Total Investment $166.92M
Weight 2.13%

Loading details…

Market Cap $74.07B
P/E Ratio 16.2
Dividends 1.8%
Total Investment $166.19M
Weight 2.12%

Loading details…

Market Cap $180.97B
P/E Ratio 31.7
Dividends 1.1%
Total Investment $164.85M
Weight 2.10%

Loading details…

Market Cap $382.74B
P/E Ratio 106.2
Dividends 3.1%
Total Investment $164.84M
Weight 2.10%

Loading details…

Market Cap $30.11B
P/E Ratio 27.7
Dividends 0.9%
Total Investment $163.9M
Weight 2.09%

Loading details…